teva pharmaceutical ind ltd
Transactions by TEVA PHARMACEUTICAL IND LTD (TEVA) in the last 6 months
Teva Pharmaceutical Industries Limited (NYSE:TEVA) made a proposal to acquire Mylan N.V. (NasdaqGS:MYL) for $31 billion on April 21, 2015. Teva offered $82 a share in cash and stock for Mylan. The consideration would comprise of approximately 50% cash and 50% stock. The proposal was unanimously approved by the Board of Directors of Teva. This proposal is subject to customary conditions. The transaction would not be subject to a financing condition or require a Teva stockholder ...
Paulson & Co. Inc.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) entered into a definitive agreement to acquire Auspex Pharmaceuticals, Inc. (NasdaqGM:ASPX) from a group of shareholders for $3.2 billion in cash on March 29, 2015. The group of shareholders includes Thomas, McNerney & Partners, Panorama Capital, CMEA Capital, Foresite Capital Management, L.L.C. and other shareholders. Under the terms of the deal, Teva will commence a tender offer for all of the outstanding shares of ...
CMEA Ventures VII, L.P.
Deerfield Capital, L.P.
Deerfield Management Company, L.P.
Deerfield Private Design Fund II, L.P.
Deerfield Private Design International II, Ltd.
Deerfield Special Situations Fund, LP
Deerfield Special Situations International Master Fund, L.P.
Foresite Capital Management, L.L.C.
Oxford Finance LLC
Panorama Capital I, L.P.
Thomas, McNerney & Partners
Thomas, McNerney & Partners II, L.P.
G & W Laboratories, Inc. signed an agreement to acquire Sellersville, Pennsylvania facility from Teva Pharmaceutical Industries Limited (NYSE:TEVA) on March 2, 2015. The transaction includes the grant to G & W of exclusive rights to sell up to two additional Teva products in the U.S. under G & W's label, which Teva will continue to manufacture at its Zagreb, Croatia facility. G & W Laboratories will offer employment to all the employees located in acquire Sellersville. ...
8800 Doral LLC acquired 78,130-square-foot building on 11.9 acres of land from Teva Pharmaceutical Industries Limited (NYSE:TEVA) for $26 million on January 14, 2015.
Soros Fund Management LLC sold a certain unknown stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA) on November 16, 2014.
|Abbott Laboratories||$47.00 USD||+0.31|
|AbbVie Inc||$64.68 USD||+0.36|
|Baxter International Inc||$69.94 USD||+0.51|
|Eli Lilly & Co||$73.05 USD||-0.07|
|Medtronic PLC||$75.90 USD||+0.30|
|View Industry Companies|